Langerhans Cells and HIV Infection

Colette Dezutter-Dambuyant,Anne-Sophie Charbonnier,Marie-Madeleine Fiers,Pascale Delorme,Nathalie Dusserre,Catherine Tsagarakis,Claude Desgranges,François Mallet,Daniel Schmitt
DOI: https://doi.org/10.1007/978-3-662-22497-7_11
1995-01-01
Abstract:The skin and mucosa are the first line of defense of the organism against external agents, not only as a physical barrier between the body and the environment but also as the site of initiation of immune reactions. The immunocompetent cells which act as antigen-presenting cells are Langerhans cells (LC). Originating in the bone marrow, LC migrate to the peripheral epithelia (skin, mucous membranes) where they play a primordial role in the induction of an immune response and are especially active in stimulating naive T lymphocytes in the primary response through a specific cooperation with CD4-positive lymphocytes after migration to proximal lymph nodes. Apart from many plasma membrane determinants, LC also express CD4 molecules which make them a susceptible target and reservoir for human immunodeficiency virus type 1 (HIV-1). Once infected, these cells, due to their localization in areas at risk (skin, mucous membranes), to their ability to migrate from the epidermal compartment to lymph nodes and to their ability to support viral replication without major cytopathic effects, could play a role as a vector in the dissemination of virus from the site of inoculation to the lymph nodes, and may thereby contribute to the infection of T lymphocytes. The in vivo consequences resulting from LC infection in the pathobiology of HIV will be discussed.
What problem does this paper attempt to address?